.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Argus Health
Cerilliant
Farmers Insurance
Fish and Richardson
Covington
Deloitte
Dow
Queensland Health

Generated: December 13, 2017

DrugPatentWatch Database Preview

BUSPAR Drug Profile

« Back to Dashboard

When do Buspar patents expire, and when can generic versions of Buspar launch?

Buspar is a drug marketed by Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in BUSPAR is buspirone hydrochloride. There are eighteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
Drug patent expirations by year for BUSPAR

Medical Subject Heading (MeSH) Categories for BUSPAR

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Bristol Myers SquibbBUSPARbuspirone hydrochlorideCAPSULE;ORAL021190-001Dec 20, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbBUSPARbuspirone hydrochlorideTABLET;ORAL018731-003Apr 22, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbBUSPARbuspirone hydrochlorideCAPSULE;ORAL021190-004Dec 20, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbBUSPARbuspirone hydrochlorideTABLET;ORAL018731-004Apr 22, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbBUSPARbuspirone hydrochlorideCAPSULE;ORAL021190-002Dec 20, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbBUSPARbuspirone hydrochlorideCAPSULE;ORAL021190-003Dec 20, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbBUSPARbuspirone hydrochlorideTABLET;ORAL018731-002Sep 29, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbBUSPARbuspirone hydrochlorideTABLET;ORAL018731-001Sep 29, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
McKinsey
Farmers Insurance
Mallinckrodt
UBS
Express Scripts
Accenture
QuintilesIMS
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot